202 related articles for article (PubMed ID: 28826798)
1. Risk of stroke in congestive heart failure with and without atrial fibrillation.
Kang SH; Kim J; Park JJ; Oh IY; Yoon CH; Kim HJ; Kim K; Choi DJ
Int J Cardiol; 2017 Dec; 248():182-187. PubMed ID: 28826798
[TBL] [Abstract][Full Text] [Related]
2. CHA
Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
[TBL] [Abstract][Full Text] [Related]
4. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
5. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
[TBL] [Abstract][Full Text] [Related]
6. CHA
Parsons C; Patel SI; Cha S; Shen WK; Desai S; Chamberlain AM; Luis SA; Aguilar MI; Demaerschalk BM; Mookadam F; Shamoun F
Mayo Clin Proc; 2017 Mar; 92(3):360-369. PubMed ID: 28259228
[TBL] [Abstract][Full Text] [Related]
7. Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score.
Lip GY; Skjøth F; Rasmussen LH; Larsen TB
J Am Coll Cardiol; 2015 Apr; 65(14):1385-94. PubMed ID: 25770314
[TBL] [Abstract][Full Text] [Related]
8. Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study.
Fauchier L; Clementy N; Pelade C; Collignon C; Nicolle E; Lip GY
Stroke; 2015 Sep; 46(9):2432-7. PubMed ID: 26251249
[TBL] [Abstract][Full Text] [Related]
9. Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.
Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Prostran MS; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):319-26. PubMed ID: 22319004
[TBL] [Abstract][Full Text] [Related]
10. CHA
Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672
[TBL] [Abstract][Full Text] [Related]
11. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
12. The CHA
Marzouka GR; Rivner H; Mehta V; Lopez J; Vaz I; Tang F; Ishwaran H; Goldberger JJ
Am J Cardiol; 2021 Sep; 155():72-77. PubMed ID: 34274114
[TBL] [Abstract][Full Text] [Related]
13. Novel composite scoring system to predict unknown atrial fibrillation in acute ischemic stroke patients.
Liu R; Yang X; Li S; Jiang Y; Wang Y; Wang Y
Brain Res; 2017 Nov; 1674():36-41. PubMed ID: 28823956
[TBL] [Abstract][Full Text] [Related]
14. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
[TBL] [Abstract][Full Text] [Related]
15. Leukoaraiosis and stroke recurrence risk in patients with and without atrial fibrillation.
Ntaios G; Lip GY; Lambrou D; Papavasileiou V; Manios E; Milionis H; Spengos K; Makaritsis K; Vemmos K
Neurology; 2015 Mar; 84(12):1213-9. PubMed ID: 25695964
[TBL] [Abstract][Full Text] [Related]
16. Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA
Lee SR; Choi EK; Han KD; Cha MJ; Oh S
Int J Cardiol; 2017 Jun; 236():226-231. PubMed ID: 28233629
[TBL] [Abstract][Full Text] [Related]
17. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
[TBL] [Abstract][Full Text] [Related]
18. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
[TBL] [Abstract][Full Text] [Related]
19. Echocardiographic parameters versus CHA2DS2-VASc score in prediction of overall cardiac events, heart failure, and stroke in non-valvular atrial fibrillation.
Yang LT; Tsai WC; Su HM
Cardiol J; 2018; 25(1):60-71. PubMed ID: 28714523
[TBL] [Abstract][Full Text] [Related]
20. Predicting stroke and death in patients with heart failure using CHA
Son MK; Lim NK; Park HY
BMC Cardiovasc Disord; 2019 Aug; 19(1):193. PubMed ID: 31395009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
